Filter
473
Filtered Results: 473
Text search:
chlamydia
Featured
Recommendations
57
New Publications
131
Language
Document type
No document type
279
Guidelines
84
Studies & Reports
52
Manuals
24
Fact sheets
12
Strategic & Response Plan
8
Training Material
6
Brochures
4
Infographics
3
Situation Updates
1
Countries / Regions
India
15
South Africa
14
Nepal
13
Global
11
Tanzania
11
Philippines
9
Germany
9
Kenya
8
Rwanda
8
Ukraine
7
Nigeria
7
Africa
7
Western and Central Europe
7
Cameroon
5
Congo, Democratic Republic of
5
Paraguay
5
Argentina
5
Russia
5
Namibia
5
Indonesia
5
Lesotho
4
Brazil
4
Ethiopia
4
Zambia
4
Senegal
3
Zimbabwe
3
Asia
3
Latin America and the Carribbean
3
Bangladesh
3
Uganda
3
Switzerland
2
Ghana
2
Benin
2
Sierra Leone
2
Togo
2
Peru
2
Mozambique
2
Eastern Europe
2
Central African Republic
2
Botswana
2
Liberia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Chile
1
Syria
1
Albania
1
Burkina Faso
1
Malawi
1
Haiti
1
Cambodia
1
Turkmenistan
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Yemen
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
165
Women & Child Health
55
Clinical Guidelines
50
Public Health
17
Capacity Building
15
Key Resources
8
Pharmacy & Technologies
5
Toolboxes
HIV
83
NTDs
42
Refugee
25
AMR
23
Pharmacy
14
TB
12
Rapid Response
10
COVID-19
10
Caregiver
9
Conflict
7
Disability
5
Mental Health
4
NCDs
4
Planetary Health
3
Global Health Education
3
Ebola & Marburg
2
Zika
2
Specific Hazards
1
Weekly Epidemiological Record. This report summarizes application of the SAFE strategy against trachoma during 2023. It includes estimates of the global population at risk of trachoma blindness based on district-by-district data submitted to WHO by national programmes. Summarizing the epidemiologica...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
Accessed October 2014
Accessed: 08.11.2020
WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform.
WHO has developed a clinical characterization case ...
This guide has been written for managers of national and district trachoma control programmes. It sets out, step-by-step, what is needed to assess the magnitude and extent of the trachoma problem in the area and how to plan, implement, monitor and evaluate a programme to control, and ultimately elim...
A Training Course for Service Providers
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
